MCO
67
3
MDLZ
28
2
DLTR
52
8
CAH
44
7
AMGN
42
14
SLB
41
2
FSLR
50
6
MAT
41
2
PWR
63
3
MET
58
2
UNH
42
6
AA
27
5
AMAT
33
3
CCI
30
2
IRM
33
5
EFX
43
3
HSY
32
3
DUK
49
4
NKE
36
2
KIM
58
2
MCO
67
3
MDLZ
28
2
DLTR
52
8
CAH
44
7
AMGN
42
14
SLB
41
2
FSLR
50
6
MAT
41
2
PWR
63
3
MET
58
2
UNH
42
6
AA
27
5
AMAT
33
3
CCI
30
2
IRM
33
5
EFX
43
3
HSY
32
3
DUK
49
4
NKE
36
2
KIM
58
2
Financhill
Back

Autolus Therapeutics PLC 10K Form

Sell
22

AUTL
Autolus Therapeutics PLC

Last Price:
$2.29
Seasonality Move:
-14.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AUTL News And Ratings

See the #1 stock for the next 7 days that we like better than AUTL

AUTL Financial Statistics

Sales & Book Value

Annual Sales: $1.7M
Cash Flow: $-86.3M
Price / Cash Flow: 0
Annual Sales: $1.79
Price / Book: 1.28

Profitability

EPS (TTM): -1.22000
Net Income (TTM): $-270.2M
Gross Margin: --
Return on Equity: -80.74%
Return on Assets: -42.65%

Autolus Therapeutics PLC Earnings Forecast

Key Autolus Therapeutics PLC Financial Ratios

  • The Research & Development expenses have been 7,684.39% of Revenue.
  • The Interest Expense is -21.63% of Operating Income.
  • The Net Earning history of AUTL is -12,272.26% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

Autolus Therapeutics PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AUTL
CUSIP: 05280R
Website: autolus.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 18.29
Quick Ratio: 17.97

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AUTL Technical Analysis vs Fundamental Analysis

Sell
22
Autolus Therapeutics PLC (AUTL) is a Sell

Is Autolus Therapeutics PLC a Buy or a Sell?